IL133623A0 - Antithrombotic agents - Google Patents
Antithrombotic agentsInfo
- Publication number
- IL133623A0 IL133623A0 IL13362398A IL13362398A IL133623A0 IL 133623 A0 IL133623 A0 IL 133623A0 IL 13362398 A IL13362398 A IL 13362398A IL 13362398 A IL13362398 A IL 13362398A IL 133623 A0 IL133623 A0 IL 133623A0
- Authority
- IL
- Israel
- Prior art keywords
- antithrombotic agents
- prodrug
- compound
- inhibitor
- factor
- Prior art date
Links
- 239000003146 anticoagulant agent Substances 0.000 title 1
- 229960004676 antithrombotic agent Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000000651 prodrug Substances 0.000 abstract 2
- 229940002612 prodrug Drugs 0.000 abstract 2
- 108010074860 Factor Xa Proteins 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Materials For Medical Uses (AREA)
- External Artificial Organs (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5088897P | 1997-06-26 | 1997-06-26 | |
| PCT/US1998/013416 WO1999000128A1 (en) | 1997-06-26 | 1998-06-26 | Antithrombotic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL133623A0 true IL133623A0 (en) | 2001-04-30 |
Family
ID=21968102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13362398A IL133623A0 (en) | 1997-06-26 | 1998-06-26 | Antithrombotic agents |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US6372759B1 (de) |
| EP (1) | EP1019045B1 (de) |
| JP (1) | JP2002508771A (de) |
| AT (1) | ATE297203T1 (de) |
| AU (1) | AU8270298A (de) |
| CA (1) | CA2294240A1 (de) |
| DE (1) | DE69830504T2 (de) |
| ES (1) | ES2241151T3 (de) |
| IL (1) | IL133623A0 (de) |
| WO (1) | WO1999000128A1 (de) |
Families Citing this family (68)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996028427A1 (en) | 1995-03-10 | 1996-09-19 | Berlex Laboratories, Inc. | Benzamidine derivatives their preparation and their use as anti-coagulants |
| EP1007037A4 (de) | 1997-06-26 | 2004-10-06 | Lilly Co Eli | Antithrombose mittel |
| ATE306261T1 (de) | 1997-06-26 | 2005-10-15 | Lilly Co Eli | Antithrombosemittel |
| AU8270298A (en) | 1997-06-26 | 1999-01-19 | Eli Lilly And Company | Antithrombotic agents |
| EP1014962A4 (de) | 1997-06-26 | 2007-06-27 | Lilly Co Eli | Antitrombotische mitteln |
| US6686364B2 (en) | 1997-12-08 | 2004-02-03 | Berlex Laboratories, Inc. | Benzamidine derivatives and their use as anti-coagulants |
| US6140351A (en) * | 1997-12-19 | 2000-10-31 | Berlex Laboratories, Inc. | Ortho-anthranilamide derivatives as anti-coagulants |
| PT1040108E (pt) | 1997-12-19 | 2004-06-30 | Schering Ag | Derivados de orto-antranilamida como anticoagulantes |
| US6262088B1 (en) | 1998-11-19 | 2001-07-17 | Berlex Laboratories, Inc. | Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants |
| EP1140903B1 (de) | 1998-12-23 | 2004-08-04 | Eli Lilly And Company | Aromatische amiden |
| ES2196917T3 (es) * | 1998-12-23 | 2003-12-16 | Lilly Co Eli | Amidas heteroaromaticas como inhibidores del factor xa`. |
| DE69931393T2 (de) | 1998-12-23 | 2007-03-29 | Eli Lilly And Co., Indianapolis | Antithrombotische amide |
| US6689780B1 (en) | 1998-12-23 | 2004-02-10 | Eli Lilly And Company | Heteroroaromatic amides as inhibitor of factor Xa |
| DE69915687T2 (de) | 1998-12-24 | 2005-02-10 | Eli Lilly And Co., Indianapolis | Heterocyclische amide als inhibitoren von faktor xa |
| US6716838B1 (en) | 1999-05-19 | 2004-04-06 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents |
| US6653316B1 (en) | 1999-05-19 | 2003-11-25 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade |
| US7015230B1 (en) | 1999-05-19 | 2006-03-21 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade |
| US6458952B1 (en) | 1999-05-19 | 2002-10-01 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade |
| US6750342B1 (en) | 1999-05-19 | 2004-06-15 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade |
| US6867217B1 (en) | 1999-05-19 | 2005-03-15 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade |
| US6664255B1 (en) | 1999-05-19 | 2003-12-16 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
| US6673817B1 (en) * | 1999-05-24 | 2004-01-06 | Millennium Pharmaceuticals, Inc. | Inhibitors of factor Xa |
| CA2375920A1 (en) | 1999-06-14 | 2000-12-21 | Eli Lilly And Company | Compounds |
| US6350761B1 (en) | 1999-07-30 | 2002-02-26 | Berlex Laboratories, Inc. | Benzenamine derivatives as anti-coagulants |
| AU6762400A (en) * | 1999-08-12 | 2001-03-13 | Cor Therapeutics, Inc. | Inhibitors of factor xa |
| HU230773B1 (hu) * | 1999-09-17 | 2018-03-28 | Millennium Pharmaceuticals, Inc. | Benzamidok és rokon Xa faktor inhibitorok |
| US6844367B1 (en) | 1999-09-17 | 2005-01-18 | Millennium Pharmaceuticals, Inc. | Benzamides and related inhibitors of factor Xa |
| US6720317B1 (en) | 1999-09-17 | 2004-04-13 | Millennium Pharmaceuticals, Inc. | Inhibitors of factor Xa |
| US6376515B2 (en) | 2000-02-29 | 2002-04-23 | Cor Therapeutics, Inc. | Benzamides and related inhibitors of factor Xa |
| US6660885B2 (en) | 2000-03-13 | 2003-12-09 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade |
| EP1272483A2 (de) * | 2000-03-24 | 2003-01-08 | Millenium Pharmaceuticals, Inc. | Oxindole als faktor xa inhibitoren |
| AU776053B2 (en) | 2000-03-31 | 2004-08-26 | Astellas Pharma Inc. | Diazepan derivatives or salts thereof |
| PT1268463E (pt) | 2000-04-05 | 2005-05-31 | Pharmacia Corp | 4-pironas substituidas com arilo e heteroarilo policiclicos uteis para a inibicao selectiva da cascata de coagulacao |
| US6693121B2 (en) | 2000-04-05 | 2004-02-17 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade |
| EP1274676A2 (de) | 2000-04-17 | 2003-01-15 | Pharmacia Corporation | Polycyclische aryl- und heteroaryl- substuierte 1,4-chinone zur selektiven hemmung des blutgerinnungsprozesses |
| GB0030303D0 (en) | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
| GB0030305D0 (en) | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
| GB0030306D0 (en) | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
| GB0030304D0 (en) | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
| WO2002010154A2 (en) | 2000-07-27 | 2002-02-07 | Eli Lilly And Company | Substituted heterocyclic amides |
| WO2002014308A1 (en) | 2000-08-17 | 2002-02-21 | Eli Lilly And Company | Antithrombotic agents |
| CA2430037A1 (en) | 2000-11-20 | 2002-05-30 | Michael S. South | Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
| US7015223B1 (en) | 2000-11-20 | 2006-03-21 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade |
| US7119094B1 (en) | 2000-11-20 | 2006-10-10 | Warner-Lambert Company | Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade |
| CN1283626C (zh) | 2000-11-22 | 2006-11-08 | 安斯泰来制药有限公司 | 取代苯衍生物或其盐 |
| WO2002064567A2 (en) | 2000-11-28 | 2002-08-22 | Eli Lilly And Company | Substituted carboxamides as inhibitors of factor xa |
| US7105682B2 (en) | 2001-01-12 | 2006-09-12 | Amgen Inc. | Substituted amine derivatives and methods of use |
| US6878714B2 (en) * | 2001-01-12 | 2005-04-12 | Amgen Inc. | Substituted alkylamine derivatives and methods of use |
| US20030134836A1 (en) * | 2001-01-12 | 2003-07-17 | Amgen Inc. | Substituted arylamine derivatives and methods of use |
| US6995162B2 (en) * | 2001-01-12 | 2006-02-07 | Amgen Inc. | Substituted alkylamine derivatives and methods of use |
| US7102009B2 (en) | 2001-01-12 | 2006-09-05 | Amgen Inc. | Substituted amine derivatives and methods of use |
| US6998408B2 (en) | 2001-03-23 | 2006-02-14 | Bristol-Myers Squibb Pharma Company | 6-5, 6-6, or 6-7 Heterobicycles as factor Xa inhibitors |
| TWI283665B (en) * | 2001-09-13 | 2007-07-11 | Smithkline Beecham Plc | Novel urea compound, pharmaceutical composition containing the same and its use |
| JP2005519866A (ja) | 2001-10-03 | 2005-07-07 | ファルマシア・コーポレーション | 凝固カスケードの選択阻害に有用な６員複素環式化合物 |
| JP2005525413A (ja) | 2001-10-03 | 2005-08-25 | ファルマシア・コーポレーション | 凝固カスケードの選択的抑制に有用な置換５員多環状化合物 |
| AU2002350172A1 (en) | 2001-12-07 | 2003-06-23 | Eli Lilly And Company | Substituted heterocyclic carboxamides with antithrombotic activity |
| US7307088B2 (en) * | 2002-07-09 | 2007-12-11 | Amgen Inc. | Substituted anthranilic amide derivatives and methods of use |
| HUE025683T2 (hu) | 2002-12-03 | 2016-04-28 | Pharmacyclics Llc | VIIA faktor inhibitor 2-(2-hidroxi-bifenil-3-il)-1H-benzoimidazol-5-karboxamidin-származékok |
| JP2006519806A (ja) * | 2003-03-07 | 2006-08-31 | グラクソ グループ リミテッド | 尿素誘導体および疼痛治療におけるバニロイド受容体拮抗剤としてのそれらの使用。 |
| DE602004011064T2 (de) * | 2003-05-30 | 2008-12-11 | Eli Lilly And Co., Indianapolis | Antitrombotische aether |
| EP1670783A2 (de) | 2003-09-30 | 2006-06-21 | Eli Lilly And Company | Aromatische ether mit antithrombotischer wirkung |
| US7700628B2 (en) | 2004-11-24 | 2010-04-20 | Eli Lilly And Company | Aromatic ether derivatives useful as thrombin inhibitors |
| DE602005016297D1 (de) * | 2004-11-29 | 2009-10-08 | Lilly Co Eli | Antithrombotische diamide |
| US7264402B2 (en) * | 2005-03-10 | 2007-09-04 | Corning Cable Systems Llc | Multi-fiber optic receptacle and plug assembly |
| US8247556B2 (en) * | 2005-10-21 | 2012-08-21 | Amgen Inc. | Method for preparing 6-substituted-7-aza-indoles |
| CA2624859A1 (en) * | 2005-11-04 | 2007-08-02 | Wyeth | Selective acylation of 4-substituted-1,3-phenylenediamine |
| ES2382055T3 (es) | 2006-11-02 | 2012-06-04 | Millennium Pharmaceuticals, Inc. | Métodos para sintetizar sales farmacéuticas de un inhibidor del factor Xa |
| CN104583194A (zh) | 2012-05-11 | 2015-04-29 | 艾伯维公司 | 作为nampt抑制剂的哒嗪和吡啶衍生物 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2414529A1 (fr) | 1978-01-13 | 1979-08-10 | Ugine Kuhlmann | Nouveaux derives de phtalones, utilisables comme pigments |
| JPH06778B2 (ja) | 1985-01-14 | 1994-01-05 | 住友化学工業株式会社 | ベンゾトリアゾール誘導体およびそれを有効成分とする除草剤 |
| ZA928276B (en) | 1991-10-31 | 1993-05-06 | Daiichi Seiyaku Co | Aromatic amidine derivates and salts thereof. |
| US5612360A (en) * | 1992-06-03 | 1997-03-18 | Eli Lilly And Company | Angiotensin II antagonists |
| EP0684830B1 (de) | 1993-02-12 | 1999-06-16 | Corvas International, Inc. | Inhibitoren gegen thrombose |
| US5721214A (en) | 1995-06-07 | 1998-02-24 | Cor Therapeutics, Inc. | Inhibitors of factor Xa |
| US5849759A (en) * | 1995-12-08 | 1998-12-15 | Berlex Laboratories, Inc. | Naphthyl-substituted benzimidazole derivatives as anti-coagulants |
| ZA985247B (en) | 1997-06-19 | 1999-12-17 | Du Pont Merck Pharma | Guanidine mimics as factor Xa inhibitors. |
| EP1014962A4 (de) | 1997-06-26 | 2007-06-27 | Lilly Co Eli | Antitrombotische mitteln |
| EP1007037A4 (de) | 1997-06-26 | 2004-10-06 | Lilly Co Eli | Antithrombose mittel |
| AU8270298A (en) | 1997-06-26 | 1999-01-19 | Eli Lilly And Company | Antithrombotic agents |
| ATE306261T1 (de) | 1997-06-26 | 2005-10-15 | Lilly Co Eli | Antithrombosemittel |
| US6140351A (en) | 1997-12-19 | 2000-10-31 | Berlex Laboratories, Inc. | Ortho-anthranilamide derivatives as anti-coagulants |
| PT1040108E (pt) * | 1997-12-19 | 2004-06-30 | Schering Ag | Derivados de orto-antranilamida como anticoagulantes |
| WO1999048878A1 (en) | 1998-03-24 | 1999-09-30 | Novo Nordisk A/S | Heterocyclic compounds regulating clotting |
| EP1140903B1 (de) | 1998-12-23 | 2004-08-04 | Eli Lilly And Company | Aromatische amiden |
| DE69931393T2 (de) | 1998-12-23 | 2007-03-29 | Eli Lilly And Co., Indianapolis | Antithrombotische amide |
| ES2196917T3 (es) | 1998-12-23 | 2003-12-16 | Lilly Co Eli | Amidas heteroaromaticas como inhibidores del factor xa`. |
| DE69915687T2 (de) | 1998-12-24 | 2005-02-10 | Eli Lilly And Co., Indianapolis | Heterocyclische amide als inhibitoren von faktor xa |
| US6314122B1 (en) | 1999-04-20 | 2001-11-06 | Lucent Technologies Inc. | Filament-based, optical detection apparatus |
| US6435434B1 (en) * | 2000-10-02 | 2002-08-20 | Sandvik Rock Tools, Inc. | Striker bar for disintegrating breakable materials |
-
1998
- 1998-06-26 AU AU82702/98A patent/AU8270298A/en not_active Abandoned
- 1998-06-26 JP JP50582499A patent/JP2002508771A/ja active Pending
- 1998-06-26 US US09/445,969 patent/US6372759B1/en not_active Expired - Fee Related
- 1998-06-26 WO PCT/US1998/013416 patent/WO1999000128A1/en not_active Ceased
- 1998-06-26 CA CA002294240A patent/CA2294240A1/en not_active Abandoned
- 1998-06-26 AT AT98932921T patent/ATE297203T1/de not_active IP Right Cessation
- 1998-06-26 EP EP98932921A patent/EP1019045B1/de not_active Expired - Lifetime
- 1998-06-26 DE DE69830504T patent/DE69830504T2/de not_active Expired - Fee Related
- 1998-06-26 IL IL13362398A patent/IL133623A0/xx unknown
- 1998-06-26 ES ES98932921T patent/ES2241151T3/es not_active Expired - Lifetime
-
2002
- 2002-02-22 US US10/082,453 patent/US6500851B2/en not_active Expired - Fee Related
- 2002-02-22 US US10/082,429 patent/US20030078431A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ES2241151T3 (es) | 2005-10-16 |
| US20020173518A1 (en) | 2002-11-21 |
| EP1019045A4 (de) | 2002-07-03 |
| EP1019045B1 (de) | 2005-06-08 |
| ATE297203T1 (de) | 2005-06-15 |
| WO1999000128A1 (en) | 1999-01-07 |
| US6372759B1 (en) | 2002-04-16 |
| CA2294240A1 (en) | 1999-01-07 |
| EP1019045A1 (de) | 2000-07-19 |
| US6500851B2 (en) | 2002-12-31 |
| US20030078431A1 (en) | 2003-04-24 |
| WO1999000128A9 (en) | 1999-08-05 |
| AU8270298A (en) | 1999-01-19 |
| DE69830504D1 (de) | 2005-07-14 |
| DE69830504T2 (de) | 2006-03-16 |
| JP2002508771A (ja) | 2002-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL133623A0 (en) | Antithrombotic agents | |
| IL133627A0 (en) | Antithrombotic agents | |
| AU2054700A (en) | Antithrombotic amides | |
| AU2055500A (en) | Aromatic amides | |
| AU2364600A (en) | Heteroroaromatic amides as inhibitor of factor xa | |
| BG106340A (en) | Substituted oxoazaheterocyclyl compounds | |
| AU2001280438A1 (en) | Substituted heterocyclic amides | |
| GB9914486D0 (en) | Medicaments | |
| YU69902A (sh) | Novi derivati piperazina | |
| MXPA02003977A (es) | Inhibidores de adhesion de celula mediada por al°2. | |
| EA199900937A1 (ru) | Фармацевтические композиции, содержащие вориконазол | |
| MY113733A (en) | Salts of an anti-migraine indole derivative | |
| CA2244785A1 (en) | Pentafluorobenzenesulfonamides and analogs | |
| AU2364000A (en) | Heterocyclic amides as inhibitors of factor xa | |
| AU2001282871A1 (en) | Antithrombotic agents | |
| AU7270798A (en) | Antithrombotic agents | |
| MY139228A (en) | Imidazolinylmethyl aralkylsulfonamides | |
| AU2001246999A1 (en) | New neurokinin antagonists for use as medicaments | |
| AU5390900A (en) | Potassium channel blocking agents | |
| EP1027051A4 (de) | Antithrombotische mittel | |
| ATE282608T1 (de) | Chinoxalindionen | |
| DE602004011064D1 (en) | Antitrombotische aether | |
| AU1434201A (en) | Antithrombotic agents | |
| EP0980366A4 (de) | Antithrombosemittel | |
| DE69528984D1 (de) | Hemmung der leukotrienbiosynthese mittels harnstoffderivaten |